RT Journal Article
SR Electronic
T1 COVID-19 Trends at The University of Tennessee: Predictive Insights from Raw Sewage SARS-CoV-2 Detection and Evaluation and PMMoV as an Indicator for Human Waste
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.03.24302256
DO 10.1101/2024.02.03.24302256
A1 Li, Y.
A1 Ash, K. T.
A1 Alamilla, I.
A1 Joyner, D. C.
A1 Williams, D. E.
A1 McKay, P. J.
A1 Green, B. M.
A1 DeBlander, S. E.
A1 North, C. M.
A1 Kara-Murdoch, F.
A1 Swift, C. M.
A1 Hazen, T. C.
YR 2024
UL http://medrxiv.org/content/early/2024/02/04/2024.02.03.24302256.abstract
AB Wastewater-based epidemiology (WBE) has become a valuable tool for monitoring the prevalence of SARS-CoV-2 on university campuses. However, concerns about effectiveness of raw sewage as a COVID-19 early warning system still exist, and it’s not clear how useful normalization by simultaneous comparison of Pepper Mild Mottle Virus (PMMoV) is in addressing variations resulting from fecal discharge dilution. This study aims to contribute insights into these aspects by conducting an academic-year field trial at the student residences on the University of Tennessee, Knoxville campus, raw sewage. This was done to investigate the correlations between SARS-CoV-2 concentrations, both with and without PMMoV normalization, and various parameters, including active COVID-19 cases, self-isolations, and their combination among all student residents. Significant positive correlations between SARS-CoV-2 concentrations a week prior, during the monitoring week, and the subsequent week with active cases. Despite these correlations, normalization by PMMoV does not enhance these associations. These findings suggest the potential utility of SARS-CoV-2 concentrations as an early warning indicator and provide valuable insights into the application and limitations of WBE for COVID-19 surveillance, specifically within the context of raw sewage on university campuses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe University of Tennessee Office of ResearchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of University of Tennessee Knoxville waived ethical approval for this work IBC-20-549-2I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors